Ind-Swift Limited

NSE INDSWFTLTD.NS

Ind-Swift Limited Net Income Margin for the year ending March 31, 2024: 2.83%

Ind-Swift Limited Net Income Margin is 2.83% for the year ending March 31, 2024, a -55.30% change year over year. Net Income Ratio, also known as the profit margin, is the ratio of net income to net sales, showing the percentage of revenue that remains as profit after all expenses are deducted.
  • Ind-Swift Limited Net Income Margin for the year ending March 31, 2023 was 6.34%, a 225.86% change year over year.
  • Ind-Swift Limited Net Income Margin for the year ending March 31, 2022 was -5.03%, a 39.89% change year over year.
  • Ind-Swift Limited Net Income Margin for the year ending March 31, 2021 was -8.37%, a -44.31% change year over year.
  • Ind-Swift Limited Net Income Margin for the year ending March 31, 2020 was -5.80%, a -390.60% change year over year.
Key data
Date Net Income Margin EBITDA Margin EBIT Margin EBITDA
Market news
Loading...
SV Wall Street
NSE: INDSWFTLTD.NS

Ind-Swift Limited

CEO Dr. Gopal Munjal M.D.
IPO Date Oct. 18, 2004
Location India
Headquarters 781, Industrial Area
Employees 1,054
Sector Healthcare
Industries
Description

Ind-Swift Limited manufactures and sells pharmaceutical formulations, finished goods dosages, active pharmaceutical ingredients, and herbal products in India. It offers medicines for various therapeutic segments, such as ENT, dentistry, anti-infective, cardio-diabetic, and orthopedic therapies under the Zoxiclav, Glypar, Olmiswif, Telhim, Ozodom-DSR, Cefextil-O, Swiclo-Sp, Swifix-O, Swifix 200, Stemin, and Stemin Forte names; gynecology, pediatrics, dermatology, and GP under the Anin, Suprox, Cozy, Distone, and Oliade name; and antibiotic, anti-cold, nutraceuticals, anti-diarrheal, anti-malarial, anti-depressants, cardiology, diabetology, neurology, and oncology. The company also provides contract research and manufacturing services. It serves government dispensaries, doctors, and hospitals through retailers, stockists, and carrying and forwarding channels. The company exports its products to approximately 50 countries. Ind-Swift Limited was founded in 1983 and is based in Chandigarh, India.

Similar companies

INDBANK.NS

Indbank Merchant Banking Services Limited

USD 0.44

-1.50%

BLBLIMITED.NS

BLB Limited

USD 0.24

2.38%

INDSWFTLAB.NS

Ind-Swift Laboratories Limited

USD 1.29

2.70%

JAGSNPHARM.NS

Jagsonpal Pharmaceuticals Limited

USD 2.88

0.21%

JAYNECOIND.NS

Jayaswal Neco Industries Limited

USD 0.44

4.17%

StockViz Staff

February 2, 2025

Any question? Send us an email